Selected Publications
Adra N, Vaughn DJ, Einhorn LH, Hanna NH, Funt SA, Rosales M, Arozullah A, Feldman DR: A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Investigational New Drugs
40 (5): 1087-1094,2022.
Shahbazi M, Zhang X, Dinh PC, Sanchez VA, Trendowski MR, Shuey MM, Nguyen T; Regeneron Genetics Center, Feldman DR, Vaughn DJ, Fung C, Kollmannsberger C, Martin NE, Einhorn LH, Cox NJ, Frisina RD, Travis LB, Dolan ME: Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer Cancer Medicine : 2022.
Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, Pluta J, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Bishop DT, Chanock SJ, Chen C, Cortessis VK, Dalgaard MD, Daneshmand S, Ferlin A, Foresta C, Frone MN, Gamulin M, Gietema JA, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Karlsson R, Kiemeney LA, Lessel D, Lista P, Lothe RA, Loveday C, Meijer C, Nead KT, Nsengimana J, Skotheim RI, Turnbull C, Vaughn DJ, Wiklund F, Zheng T, Zitella A, Schwartz SM, McGlynn KA, Kanetsky PA, Nathanson KL, Richiardi L.: Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk Cancer Epidemiology Biomarkers Prevention
31 (9): 1769-1779,2022.
Roberson D, Jia H, Vaughn D, Miller C, Fogt F, Kovell RC: Effective control of recurrent and metastatic GU SCC by employing a multimodal approach in a patient with a history of radiation and transscrotal surgery for stage I seminoma Urology Case Reports 45 : 102223,2022.
Lin JK, Jacobs LA, Blauch A, Shulman LN, Vaughn DJ: Guideline discordant care in patients with metastatic germ cell tumors Urologic Oncology: Seminars and Original Investigations
Urol Oncol. 2022 Aug;40(8):385.e9-385.e17. 40 (8): 385.e9-385.e17,2022.
Zhang X, Trendowski MR, Wilkinson E, Shahbazi M, Dinh PC, Shuey MM; Regeneron Genetics Center, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Huddart R, Martin NE, Sanchez VA, Frisina RD, Einhorn LH, Cox NJ, Travis LB, Dolan ME.: Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.
Cancer Medicine
11 (14): 2801-2816,2022.
Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB.: Ototoxicity after cisplatin-based chemotherapy: factors associated with discrepancies between patient-reported outcomes and audiometric assessments.
Ear and Hearing
43 (3): 794-807,2022.
Vaughn DJ, Jacobs LA: Approach to the care of long-term testicular cancer survivors UpToDate : 2022.
Vaughn DJ: Discovery and Healing: Reflections on Five Decades of Hematology/Oncology at the Perelman School of Medicine at the University of Pennsylvania. University of Pennsylvania Press, Philadelphia : 2022.
Vaughn DJ: Testicular Cancer Harrison's Principles of Internal Medicine, 21st Edition : 2022.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-114
3400 Civic Center Blvd
Philadelphia,
PA
19104-4283
Phone: 215-349-8140
Patient appointments: 800-789-7366